Meeting
2018 ASCO Annual Meeting
NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC).
Authors
Dolores Isla
Hospital Clínico Lozano Blesa, Zaragoza, Spain
Dolores Isla , Margarita Majem , Maria Guirado , Bartomeu Massuti , Ramon De Las Penas , Ana Laura Ortega Granados , Manuel Domine , Raquel Marse Fabregat , Maria Angeles Sala Gonzalez , Alfredo Paredes , Teresa Moran , Sergio Vazquez Estévez , Juan Coves , Jose Luis Gonzalez Larriba , Miguel Sánchez , David Vicente , Nuria Farre , Luis Fernandez Fornos , Francisco Valcarcel , Mariano Provencio-Pulla
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Clinical Trial Registration Number
EudraCT 2015-003312-21
Citation
J Clin Oncol 36, 2018 (suppl; abstr 8537)
DOI
10.1200/JCO.2018.36.15_suppl.8537
Abstract #
8537
Poster Bd #
143
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Randomized phase II trial (RENO): efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC). SLCG 10/02.
First Author: Mariano Provencio
Poster
2013 ASCO Annual Meeting
Prospective randomised phase II trial of oral vinorelbine (NVBo) and cisplatin (P) or pemetrexed (Pem) and P in first-line metastatic or locally advanced non-small cell lung cancer (M or LA NSCLC) with nonsquamous (Non SCC) histological type. NAVoTRIAL01: Final results.
First Author: Jaafar Bennouna
Poster
2012 ASCO Annual Meeting
Prospective randomized phase II trial of oral vinorelbine (NVBo) and cisplatin (P) or pemetrexed (Pem) and P in first-line metastatic or locally advanced non-small cell lung cancer (M or LA NSCLC) patients (pts) with nonsquamous (non SCC) histologic type: NAVoTRIAL01—Preliminary results.
First Author: Jaafar Bennouna
Poster
2023 ASCO Annual Meeting
Induction therapy of toripalimab combined with docetaxel and cisplatin in locally advanced hypopharyngeal squamous cell carcinoma (HPSCC): A single-arm, phase II clinical trial.
First Author: Chunmei Bai